Shukra Pharmaceuticals Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹23.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 272.15 per cent from ₹6.32 crore. This corresponds to a year-on-year *(YoY) growth of 336.36 per cent.
Operating Profit
Operating Profit stands at ₹19.14 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2,634.29 per cent from ₹0.70 crore. This corresponds to a year-on-year *(YoY) growth of 1,350.00 per cent.
PBDT
PBDT stands at ₹19.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,284.89 per cent from ₹1.39 crore. This corresponds to a year-on-year *(YoY) growth of 787.10 per cent.
Profit Before Tax
Profit Before Tax stands at ₹18.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4,681.58 per cent from ₹0.38 crore. This corresponds to a year-on-year *(YoY) growth of 1,216.67 per cent.
Net Profit
Net Profit stands at ₹12.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 853.49 per cent from ₹-1.72 crore. This represents a 1,158.25 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Shukra Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Shukra Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Shukra Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Shukra Pharmaceuticals Ltd Financial Reports
Shukra Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Shukra Pharma. | 1.68% | 4.79% | 38.10% | 50.00% | 21.10% | 90.21% |
| Hester Bios | -0.19% | -0.53% | -0.98% | 28.81% | 52.55% | 19.22% |
| Indoco Remedies | 1.54% | 1.14% | -5.08% | 10.91% | 11.14% | -20.53% |
| Windlas Biotech | 1.71% | 4.22% | 12.29% | 22.96% | 26.30% | -3.80% |
| NGL Fine Chem | 0.46% | 3.04% | -7.44% | 8.98% | 33.71% | 114.55% |
| Titan Biotech | -1.13% | -4.52% | -7.43% | -12.68% | 44.96% | 340.63% |
| Jagsonpal Pharma | 1.59% | 0.06% | 6.12% | 11.51% | 33.72% | -0.81% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : Dakshesh Shah
Executive Director : Payal Mehta
E D & Wholetime Director : Dhruvin Shah
E D & Wholetime Director : Sanskruti Patel
Independent Non Exe. Director : Pinki Nirmal Sagar
Independent Non Exe. Director : Sonal Deepalbhai Gandhi
Independent Non Exe. Director : Sarjeevan Singh
Independent Non Exe. Director : Jitendra shah
Executive Director / Whole Time Director / CFO : Anar Jayesh Patel
E D & Wholetime Director : SHITAL DAKSHESH SHAH
Independent Non Exe. Director : Ritu Kapoor
Company Secretary / Compliance Officer : Shivkant Dhakad